Minimization of the neuropathic effects of oxalipaltin administration agree to cost-effectiveness

WCRJ 2014; 1 (3): e264

  Topic: Pharmacogenomics     Category:

De Lucia D.
Department of Neurology, Azienda Policlinico Second University of Naples, Naples, Italy
domenico.delucia@unina2.it Close
, Di Francia R.
Department of Hematology, National Cancer Institute, Fondazione “G. Pascale”, Naples, Italy Close

To cite this article

De Lucia D.
Department of Neurology, Azienda Policlinico Second University of Naples, Naples, Italy
domenico.delucia@unina2.it Close
, Di Francia R.
Department of Hematology, National Cancer Institute, Fondazione “G. Pascale”, Naples, Italy Close
Minimization of the neuropathic effects of oxalipaltin administration agree to cost-effectiveness

WCRJ 2014; 1 (3): e264

Publication History

Published online: 01 Oct 2014